Midwestern University College of Pharmacy, Downers Grove, IL, USA.
Department of Pharmacy Practice, UIC College of Pharmacy, Chicago, IL.
Am J Health Syst Pharm. 2022 Nov 22;79(23):2128-2133. doi: 10.1093/ajhp/zxac245.
Despite the expertise that emergency medicine (EM) pharmacists bring to multidisciplinary teams in the emergency department (ED) setting, they are not commonly present on writing groups for guidelines, policies, or task forces pertaining to EM pharmacotherapy. The purpose of this article is to quantify EM pharmacist involvement on author bylines of guidelines, position statements, and other official documents that specifically encompass EM pharmacotherapy.
Official work products released between January 1, 2010, and May 1, 2021, were collected from the American College of Emergency Physicians (ACEP), Society for Academic Emergency Medicine (SAEM), and American Academy of Emergency Medicine (AAEM) and the table of contents of the following journals: Annals of Emergency Medicine, Academic Emergency Medicine, and Journal of Emergency Medicine. A modified Delphi approach was used to gain consensus amongst the authors on which work products to include in the initial review and which works pertained to pharmacotherapy. The primary endpoint was the percentage of pharmacists listed as authors on EM work products pertaining to pharmacotherapy.
Overall, 76 EM work products were identified. Forty-seven work products with a total of 248 authors contained at least 1 recommendation pertaining to pharmacotherapy. Of these 47 EM work products, 23 (49%) were from AAEM, 16 (34%) were from Annals of Emergency Medicine (published on behalf of ACEP), 5 (11%) were from Journal of Emergency Medicine (published on behalf of AAEM), and 3 (6%) were from SAEM. The median number of authors per work product was 4. There were 5 pharmacists listed on work products (2% of the total of 248 authors). Additionally, there were 9 nonpharmacist/nonphysician authors (4% of the total).
Pharmacist inclusion on author lists of recently published EM work products pertaining to pharmacotherapy is extremely low. Given their unique knowledge pertaining to EM pharmacotherapy, an effort should be made to increase inclusion of pharmacists as authors of EM work products with recommendations that pertain to pharmacotherapy.
尽管急诊医学（EM）药师在急诊部（ED）多学科团队中具有专业知识，但他们通常不参与与 EM 药物治疗相关的指南、政策或工作组的编写。本文的目的是量化 EM 药师在 2010 年 1 月 1 日至 2021 年 5 月 1 日期间发布的指南、立场声明和其他专门涵盖 EM 药物治疗的正式文件中的作者署名情况。
从美国急诊医师学院（ACEP）、学术急诊医学协会（SAEM）和美国急诊医师学院（AAEM）以及以下期刊的目录中收集了 2010 年 1 月 1 日至 2021 年 5 月 1 日期间发布的正式工作成果：《急诊医学年鉴》、《学术急诊医学》和《急诊医学杂志》。采用改良德尔菲法（modified Delphi approach）让作者就纳入初步审查的工作成果以及哪些工作与药物治疗相关达成共识。主要终点是在与药物治疗相关的 EM 工作成果中列出的药师比例。
总体而言，确定了 76 项 EM 工作成果。47 项共 248 位作者的工作成果中至少包含 1 项与药物治疗相关的建议。在这 47 项 EM 工作成果中，23 项（49%）来自 AAEM，16 项（34%）来自《急诊医学年鉴》（代表 ACEP 出版），5 项（11%）来自《急诊医学杂志》（代表 AAEM 出版），3 项（6%）来自 SAEM。每项工作成果的作者中位数为 4 人。有 5 位药师（占 248 位作者总数的 2%）列入工作成果。此外，还有 9 位非药师/非医师作者（占总数的 4%）。
最近发表的与 EM 药物治疗相关的 EM 工作成果中，药师在作者名单中的比例极低。鉴于他们在 EM 药物治疗方面的独特知识，应努力增加药师作为与药物治疗相关的 EM 工作成果的作者。
